Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1))

2025/08/09 by Kevin J. Mercer, Kevin Mercer, Gavin T. Howington +11 · 1 voice · 1 citation
Medicine · #Acute Ischemic Stroke Management #Acute Myocardial Infarction Research #Cardiac Arrest and Resuscitation

paper · doi:10.1016/j.ajem.2025.08.014

openalex publication_date 2025/08/09 · crossref created 2025/08/09 · openalex created_date 2025/10/10 · crossref issued 2025/12/01 · crossref published 2025/12/01 · crossref published-print 2025/12/01 · crossref deposited 2026/01/14 · crossref indexed 2026/07/07 · openalex updated_date 2026/07/22

Citations

• The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Cited by

• Consensus Recommendations for Clinical Pharmacist Integration into the Acute Stroke Care Team: Endorsed by the American College of Clinical Pharmacy, Neurocritical Care Society, Society for Academic Emergency Medicine, and Society of Critical Care Medicine, and affirmed by the American Academy of Neurology

Discussions

• Just published in #AJEM! 📄 #PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑 Faster treatment = better outcomes A huge w [bsky, 0 points, 1 comments]